New journals seek to fill neurodiversity gap | Spectrum | Autism Research News
The two journals, although differing in initial support, both realized the need for a publication focused exclusively on the neurodiverse experience.
Private equity harms autism service market | Spectrum | Autism Research News
Time is running out to expose this disreputable push for profit over care and change insurance, funding and training practices for the better.
Null & Noteworthy: Intervention flops; neural noise; gender care | Spectrum | Autism Research News
This edition takes aim at the autism-intervention evidence base with a slew of null results, plus findings that challenge a prevailing autism brain theory.
Applied behavior analysis and autism: Flawed application of a proven science | Spectrum | Autism Research News
The field of ABA needs more compassion and individualization.
Yen for routine seeds anxiety in autistic children | Spectrum | Autism Research News
Interventions that moderate a need for ‘sameness’ may prevent anxiety traits.
Australia drafts guideline for supporting autistic children | Spectrum | Autism Research News
Government-convened experts laid out 84 recommendations, with a particular focus on affirming neurodiversity and embracing human rights.
Factors other than autism traits guide therapies for autistic children | Spectrum | Autism Research News
Most autistic children in the Netherlands have used some sort of treatment, but the number, type and timing varies depending on considerations unrelated to their condition.
Access to virtual autism therapy in US could narrow post-COVID | Spectrum | Autism Research News
When the federal public health emergency expires, so too could temporary insurance coverage of applied behavior analysis conducted remotely. A proposed rule could block those changes, however, at least for people with public insurance.
Why autism therapies have an evidence problem | Spectrum | Autism Research News
Early interventions for autism lack solid data. The source of this problem is murky but may stem from ongoing debates about evidence quality and entrenched conflicts of interest within the field.
Null and Noteworthy: An ineffective therapy and an effective biomarker | Spectrum | Autism Research News
In this edition, a strategy to help autistic children adapt their skills to new situations shows no benefit, but an early-life autism biomarker does.
Autism News International